News AC Immune SA

Equities

ACIU

CH0329023102

Real-time Estimate Cboe BZX Other stock markets 10:28:32 2024-05-22 am EDT			5-day change	1st Jan Change
3.35 ^USD	+0.30%		-3.70%	-32.40%

May. 13	Sector Update: Health Care Stocks Mixed Late Afternoon	MT
May. 13	Sector Update: Health Care	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Takeda agrees to develop active immunotherapy for Alzheimer's	May. 14	AQ
Sector Update: Health Care Stocks Mixed Late Afternoon	May. 13	MT
Sector Update: Health Care	May. 13	MT
Top Midday Gainers	May. 13	MT
AC Immune Enters Licensing Deal for Alzheimer's Disease Drug Candidate	May. 13	MT
Wall Street Set to Open Higher Monday as Investors Look Toward Key Inflation Figures	May. 13	MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Key Inflation Reports	May. 13	MT
Investors Eye Key Inflation Data in Days Ahead as US Futures Trend Modestly Higher Monday	May. 13	MT
Top Premarket Gainers	May. 13	MT
Takeda Pharmaceutical, AC Immune Agree to Option and Licence Agreement, Including on Alzheimer's Treatment Candidate	May. 13	MT
AC Immunity Shares Soar on Exclusive License Deal with Takeda	May. 13	DJ
AC Immune: Q1 Earnings Snapshot	May. 13	AQ
AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update	May. 13	AQ
AC Immune SA Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease	May. 13	AQ
AC Immune Files $350 Million Mixed Shelf	Mar. 15	MT
AC Immune SA Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update	Mar. 14	AQ
AC Immune Announces Upcoming Presentations at AD/PD™ 2024	Feb. 22	AQ
Certain Common Shares of AC Immune SA are subject to a Lock-Up Agreement Ending on 14-FEB-2024.	Feb. 13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News AC Immune SA

Equities

ACIU

CH0329023102

Summary

Filters